Metraipolis › archive › dc_0cf04162cb44

Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis — Europe PMC PMID:42084869

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42084869
DOI
10.1001/jamanetworkopen.2026.10815
License (as archived)
solo-consultazione
Archived
2026-11-02T22:50:37.773Z
SHA-256 of the archived text
fc3f6f81d32054189c39cbaa75804f6a55fdfbf78a46373295aa0d32bd0df9ec
Stable URL of this page
https://metraipolis.com/documento/dc_0cf04162cb44

How to cite

Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis — Europe PMC PMID:42084869 — Europe PMC (en), https://europepmc.org/article/MED/42084869 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cf04162cb44 (Metraipolis archive dc_0cf04162cb44, sha256 fc3f6f81d32054189c39cbaa75804f6a55fdfbf78a46373295aa0d32bd0df9ec)
BibTeX
@misc{dc0cf04162cb44,
  title = {Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis — Europe PMC PMID:42084869},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42084869},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cf04162cb44; sha256 fc3f6f81d32054189c39cbaa75804f6a55fdfbf78a46373295aa0d32bd0df9ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42084869. Agents can read the archived copy with the MCP tool read_document.